Vancouver-based psychedelic drugs company Clearmind Medicine partnered with pharmaceutical company CTS to collaborate on psychedelic-based product development.
Under the terms of agreement, Clearmind will have access to CTS’ advanced research facilities, global networks, manufacturing expertise, and marketing guidance, which will enhance its research and development capabilities for its psychedelic-based treatments.
Israel-based CTS is a leading manufacturer of pharmaceuticals, medical devices, and various consumer products. The company also engages in the marketing and distributing of global healthcare products across Israel.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.